Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention
Benjamin Bay1, Raman Sharma2, Anastasios Roumeliotis2
1Icahn School of Medicine at Mount Sinai, New York, New York; Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Insights
Patients with polyvascular disease (PolyVD) undergoing left main percutaneous coronary intervention (LM-PCI) face higher risks of major adverse cardiovascular events (MACE) and bleeding. This highlights the vulnerability of this complex patient group post-procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Percutaneous coronary intervention (PCI) is effective for select left main coronary artery disease (LM-CAD) patients.
- Polyvascular disease (PolyVD), involving multiple vascular beds, is linked to worse outcomes in coronary artery disease (CAD).
- The impact of PolyVD on outcomes after LM-PCI remains understudied.
Purpose of the Study:
- To investigate the association between PolyVD and outcomes following unprotected LM-PCI.
- To evaluate the risk of major adverse cardiovascular events (MACE) and bleeding in LM-PCI patients with and without PolyVD.
Main Methods:
- Retrospective single-center study of patients undergoing unprotected LM-PCI (2012-2019).
- Patients stratified based on the presence or absence of PolyVD (LM-CAD plus cerebrovascular and/or peripheral artery disease).
- Primary outcome: MACE (all-cause mortality or spontaneous myocardial infarction) within 1 year post-PCI.
Main Results:
- 869 patients included; 23.8% had PolyVD.
- PolyVD patients were older with more comorbidities.
- Higher 1-year MACE rates (22.8% vs 9.4%, p<0.001) and bleeding events in PolyVD group.
- MACE driven by increased all-cause mortality (18.3% vs 7.1%, p<0.001) in PolyVD group.
- Results remained significant after adjusting for confounders.
Conclusions:
- PolyVD is an independent predictor of increased MACE and bleeding risk after LM-PCI.
- Patients with PolyVD undergoing LM-PCI represent a vulnerable population requiring careful management.
- Further research into optimizing treatment strategies for this high-risk group is warranted.
Abstract:
Percutaneous coronary intervention (PCI) has demonstrated its safety and efficacy in treating left main (LM) coronary artery disease (CAD) in select patients. Polyvascular disease (PolyVD) is associated with adverse events in all-comers with CAD. However, there is little data examining the interplay between PolyVD and LM-PCI, which we sought to investigate in a retrospective single-center study. We included patients who underwent unprotected LM-PCI at a tertiary center from 2012 to 2019. The study population was stratified based on the presence or absence of PolyVD (i.e., medical history of cerebrovascular and/or peripheral artery disease in addition to LM-CAD). The primary outcome was major adverse cardiovascular events (MACE) combining all-cause mortality and spontaneous myocardial infarction within 1 year after index PCI. Overall, 869 patients were included, and 23.8% of the population had PolyVD. Subjects with PolyVD were older and had a greater burden of co-morbidities. After 1-year follow-up, PolyVD patients exhibited significantly higher rates of both MACE (22.8% vs 9.4%, p <0.001) and bleeding events compared with those without PolyVD. MACE was primarily driven by an increase in all-cause mortality (18.3% vs 7.1%, p <0.001). Results persisted after adjusting for confounders. In conclusion, in patients who underwent LM-PCI, the presence of PolyVD is linked to an increased risk of MACE and bleeding after 1 year of follow-up, which highlights the vulnerability of this population.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
